Clal Biotechnology Industries Balance Sheet Health
Financial Health criteria checks 3/6
Clal Biotechnology Industries has a total shareholder equity of ₪82.9M and total debt of ₪21.7M, which brings its debt-to-equity ratio to 26.2%. Its total assets and total liabilities are ₪107.3M and ₪24.4M respectively.
Key information
26.2%
Debt to equity ratio
₪21.72m
Debt
| Interest coverage ratio | n/a |
| Cash | ₪9.54m |
| Equity | ₪82.94m |
| Total liabilities | ₪24.38m |
| Total assets | ₪107.32m |
Recent financial health updates
Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt
Oct 09
Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?
Jan 19Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly
Mar 24Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?
Dec 07
Recent updates
Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt
Oct 09The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet
Apr 18Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)
Jul 14Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?
Jan 19Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings
Mar 25Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly
Mar 24Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year
Feb 16What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?
Jan 12Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?
Dec 07Financial Position Analysis
Short Term Liabilities: CBI's short term assets (₪10.3M) exceed its short term liabilities (₪4.7M).
Long Term Liabilities: CBI's short term assets (₪10.3M) do not cover its long term liabilities (₪19.7M).
Debt to Equity History and Analysis
Debt Level: CBI's net debt to equity ratio (14.7%) is considered satisfactory.
Reducing Debt: CBI's debt to equity ratio has increased from 7.1% to 26.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CBI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CBI has less than a year of cash runway if free cash flow continues to grow at historical rates of 10.9% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 06:36 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clal Biotechnology Industries Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pravin Gondhale | Virtua Research Inc. |